Location History:
- Tsukuba, JP (2012)
- Saitama, JP (2018)
Company Filing History:
Years Active: 2012-2018
Title: Tomotaka Yokoo: Innovator in Peptide Research
Introduction
Tomotaka Yokoo is a prominent inventor based in Saitama, Japan. He has made significant contributions to the field of peptide research, particularly in applications related to pancreatic hormone-producing cells. With a total of 2 patents, his work is paving the way for advancements in diabetes treatment.
Latest Patents
Yokoo's latest patents include a novel peptide and its applications. The first patent describes a new peptide, along with a vector that inserts DNA coding for this peptide. This peptide is designed to promote the proliferation of pancreatic hormone-producing cells. The amino acid sequence of the peptide is specified in SEQ ID NO: 1, and variations of this sequence are also included. The second patent focuses on methods for treating diabetes and increasing pancreatic beta-cells. It discloses an insulin secretion inducer and a composition aimed at enhancing the number of pancreatic beta-cells, utilizing a polypeptide encoded by the Tm4sf20 gene.
Career Highlights
Tomotaka Yokoo is affiliated with Saitama Medical University, where he conducts his research. His work has garnered attention for its potential impact on diabetes treatment and cell proliferation.
Collaborations
Yokoo collaborates with notable colleagues, including Hideo Toyoshima and Yasushi Okazaki. Their combined expertise contributes to the innovative research being conducted in the field of peptide applications.
Conclusion
Tomotaka Yokoo's contributions to peptide research are significant, particularly in the context of diabetes treatment. His innovative patents and collaborations highlight the importance of his work in advancing medical science.